Science Explorer Interactive view Map
Company · Cambridge · United States

Genocea (United States)

genocea.comROR OpenAlex
Research works
55
▼ 26% vs 2013–17
Citations
559
10.1 per fractional work
Top-10% rate
2.8%
record average 16.5%
Open access
57%
world 28%

Not ranked overall: Genocea (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.27× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 16.36× its world share, 1 worksImmunology and Micro…Chemical Engineering: 4.79× its world share, 0 worksChemical EngineeringChemistry: 4.27× its world share, 0 worksChemistryEngineering: 0.22× its world share, 0 worksEngineeringMedicine: 1.72× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 16.4×. Every wedge is a field page.

Which keywords describe research at Genocea (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Antigen Presentation, Immunity, Innate Immunity, Dendritic Cells, Tumor Antigen, Embryonic Stem Cells and Pluripotent Stem Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy10▲ 124×3 topics
  2. Antigen Presentation8▲ 145×2 topics
  3. Epidemiology7▲ 3.2×22 topics
  4. Immunity7▲ 38×3 topics
  5. Innate Immunity7▲ 35×2 topics
  6. Dendritic Cells6▲ 103×1 topic
  7. Embryonic Stem Cells6▲ 160×2 topics
  8. Tumor Antigen6▲ 146×1 topic
  9. Pluripotent Stem Cells5▲ 140×2 topics
  10. Genome Engineering5▲ 150×1 topic
  11. RNA-Guided5▲ 150×1 topic
  12. Differentiation5▲ 114×1 topic
  13. Induced Pluripotent Stem Cells5▲ 242×1 topic
  14. Immunotherapy4▲ 12×5 topics
  15. Immune Response4▲ 12×4 topics
  16. Vaccine4▲ 19×5 topics
  17. Tumor Regression4▲ 85×2 topics
  18. Genomic Integration4▲ 70×2 topics
  19. Gene Therapy4▲ 26×3 topics
  20. Tumor Microenvironment4▲ 19×4 topics
  21. Herpes Zoster3▲ 134×1 topic
  22. Herpesviruses3▲ 134×1 topic
  23. Immune Checkpoint Blockade3▲ 105×1 topic
  24. PD-1 and PD-L13▲ 105×1 topic
  25. Lymphoma3▲ 37×2 topics
  26. CAR T Cells3▲ 122×1 topic
  27. Chimeric Antigen Receptor3▲ 122×1 topic
  28. Monoclonal Antibodies3▲ 35×2 topics
  29. AAV2▲ 61×1 topic
  30. Gene Expression2▲ 6.4×2 topics
  31. Immune Evasion2▲ 70×2 topics
  32. Viral Vectors2▲ 61×1 topic
  33. Fc Receptors2▲ 38×1 topic
  34. Therapeutic Antibodies2▲ 30×1 topic
  35. Vaccine Development2▲ 11×4 topics
  36. Genetic Modification2▲ 86×1 topic
  37. Transgenic Animals2▲ 86×1 topic
  38. Antiviral Therapy2▲ 18×2 topics
  39. Infection2▲ 9.7×2 topics
  40. Transplant Recipients2▲ 32×2 topics

Which research topics does Genocea (United States) publish most on?

By volume in 2022–2025: Immunotherapy and Immune Responses, CAR-T cell therapy research, CRISPR and Genetic Engineering and Animal Genetics and Reproduction.

Immunotherapy and Immune Responses: 1 fractional worksCAR-T cell therapy research: 1 fractional worksCRISPR and Genetic Engin…0CRISPR and Genetic Engineering: 0 fractional worksAnimal Genetics and Repr…0Animal Genetics and Reproduction: 0 fractional worksVirus-based gene therapy research: 0 fractional worksSynthesis and Characterization of Heterocyclic Compounds: 0 fractional worksDNA and Nucleic Acid Che…0DNA and Nucleic Acid Chemistry: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksOdor and Emission Control Technologies: 0 fractional works
ImmunologyOncologyMolecular BiologyGenetics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 CRISPR and Genetic Engineering Molecular Biology 0 works
  4. 4 Animal Genetics and Reproduction Genetics 0 works
  5. 5 Virus-based gene therapy research Genetics 0 works
  6. 6 Synthesis and Characterization of Heterocyclic Compounds Organic Chemistry 0 works
  7. 7 DNA and Nucleic Acid Chemistry Molecular Biology 0 works
  8. 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 HER2/EGFR in Cancer Research Oncology 0 works
  10. 10 Odor and Emission Control Technologies Process Chemistry and Technology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available57.0%not open43.0%

World: 28% of research is openly available.

with international co-authors10.3%domestic only89.7%

World: 19% is written across borders.

How has Genocea (United States)'s research output changed?

Output in 2018–2022 was 26% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.